A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy

NCT00271414 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain

Interventions

DRUG: Duragesic® (fentanyl) Transdermal Therapeutic System (TTS)

Sponsor

Janssen Pharmaceutica N.V., Belgium